M
Micrima
Biotech & Life Sciences · Bristol, United Kingdom · Founded 2005
Develops and commercializes microwave radar breast imaging technology MoreLess
Micrima, a company spun out of the University of Bristol, has developed an innovative breast imaging system known as MARIA. This system utilizes microwave radar technology, a non-invasive and non-ionizing method for detecting breast cancer.
The MARIA system offers a significant advancement in breast cancer screening by providing a radiation-free and painless alternative to traditional mammography. This makes the screening process more comfortable and safer for patients, potentially encouraging more frequent and earlier testing.
Micrima's business model is focused on the development and commercialization of this technology, targeting healthcare providers such as hospitals and clinics as its primary clients. The company generates revenue through the sale of its MARIA imaging systems. The market for this technology is the global medical device industry, specifically in the area of breast cancer diagnostics, a sector with a continuous demand for more effective and patient-friendly solutions.
Keywords: breast imaging, microwave radar, medical devices, cancer diagnostics, non-invasive, radiation-free, healthcare technology, oncology, women's health, medical imaging
Talent graph
Micrima's talent
Source: Dealroom Talent Intelligence.
Investors
10 investors on Micrima's cap table
Sourced from Dealroom's funding and investor records.








Global footprint
Where Micrima has talent and traffic
Market sentiment
What the market is saying about Micrima
An AI-synthesized read of the highest-engagement posts about Micrima on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Micrima on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.